Abstract 6248: Engineered probiotics for local delivery of checkpoint blockade nanobodies
Candice R. Gurbatri(Tempus Labs (United States)), Tal Danino(Herbert Irving Comprehensive Cancer Center), Piper Treuting(University of Washington), Courtney Coker(Columbia University), Samuel Castro(Columbia University), Nicholas Arpaia(Columbia University Irving Medical Center), Rosa L. Vincent(Columbia University), Taylor E. Hinchliffe(Columbia University), Ioana Lia(Columbia University)
Cited by 5
Related Papers
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
|Biology of Blood and Marrow Transplantation|2015|762
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
|Science Translational Medicine|2020|600
Engineering bacteria as interactive cancer therapies
|Science|2022|411
Probiotic-guided CAR-T cells for solid tumor targeting
|Science|2023|251